Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Demographic and clinical characteristics of the study population. Clinical and Biochemical | NBMD, n=213 | LBMD, n=243 | p-value | Characteristics | Median (P25-P75) | Median (P25-P75): Vitamin D intake, UI/day | 111 (65-170) | 103 (69-158) | 0.3891
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Multiple reported designs.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This study is a cross-sectional analysis using a subsample from the third wave (2017 to 2019) of the Health Worker Cohort Study (HWCS).
Source: Methods.
Women were selected based on the following inclusion criteria: ≥45 years old, menopause confirmed (12 consecutive months without menstruation), and available BMD measurements.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
SHBG and APOA1 as serum biomarkers for low bone mineral density in Mexican postmenopausal women: a random forest-based analysis
Multiple reported designs · Frontiers in Endocrinology · 2026
Original publication title
SHBG and APOA1 as serum biomarkers for low bone mineral density in Mexican postmenopausal women: a random forest-based analysis
Copyright © 2026 Aparicio-Bautista, Becerra-Cervera, Rivera-Paredez, Jiménez-Ortega, López-Pérez, Salmerón, Reyes-Grajeda, Hidalgo-Bravo and Velázquez-Cruz.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To validate a set of 6 proteins as potential minimally invasive serum biomarkers, Gelsolin (GSN), Sex Hormone-Binding Globulin (SHBG), Apolipoprotein A1 (APOA1), Apolipoprotein A2 (APOA2), Ryanodine Receptor 1 (RYR1), and Ryanodine Receptor 3 (RYR3), for diagnosing low BMD in postmenopausal women. We also investigated whether a combination of these proteins can provide more informative insights into the risk of having low BMD compared to individual biomarkers.
Source: ObjectiveAbstract: What methods does the paper describe?
The enzyme-linked immunosorbent assay was carried out to measure the concentrations of these proteins in 456 serum samples from postmenopausal Mexican women with normal or low BMD.
Source: MethodsAbstract: Results
A random forest classifier demonstrated that SHBG and APOA1 are the most effective biomarkers for discriminating between women with normal or low BMD, with notable high sensitivity (86%), specificity (75%), precision (92%), and overall performance (89.32%).
Source: ResultsAbstract: Conclusions
The combination of APOA1 and SHBG correlates better with the risk of bone loss than the performance of single biomarkers in postmenopausal women. Further validation in a larger cohort is necessary to confirm these results.
Source: ConclusionsAuthors’ abstract
Background
Osteoporosis is a major health issue that has implications worldwide, both clinically and socioeconomically. Therefore, searching for informative bone health biomarkers that provide early information on bone changes and assess treatment efficacy is essential. Previously, our group used label-free proteomics and bioinformatic approaches to analyze the serum proteomic profile of postmenopausal women with normal bone mineral density (BMD), osteopenia, and osteoporosis. Based on their role in bone metabolism and literature review, a panel of 12 candidate serum biomarkers for low BMD was proposed.
Objective
To validate a set of 6 proteins as potential minimally invasive serum biomarkers, Gelsolin (GSN), Sex Hormone-Binding Globulin (SHBG), Apolipoprotein A1 (APOA1), Apolipoprotein A2 (APOA2), Ryanodine Receptor 1 (RYR1), and Ryanodine Receptor 3 (RYR3), for diagnosing low BMD in postmenopausal women. We also investigated whether a combination of these proteins can provide more informative insights into the risk of having low BMD compared to individual biomarkers.
Methods
The enzyme-linked immunosorbent assay was carried out to measure the concentrations of these proteins in 456 serum samples from postmenopausal Mexican women with normal or low BMD.
Results
A random forest classifier demonstrated that SHBG and APOA1 are the most effective biomarkers for discriminating between women with normal or low BMD, with notable high sensitivity (86%), specificity (75%), precision (92%), and overall performance (89.32%).
Conclusions
The combination of APOA1 and SHBG correlates better with the risk of bone loss than the performance of single biomarkers in postmenopausal women. Further validation in a larger cohort is necessary to confirm these results.
Publication and source details
Original title: SHBG and APOA1 as serum biomarkers for low bone mineral density in Mexican postmenopausal women: a random forest-based analysis
Diana I Aparicio-Bautista; Adriana Becerra-Cervera; Berenice Rivera-Paredez; Rogelio F Jiménez-Ortega; Tania V López-Pérez; Jorge Salmerón; J. Pablo Reyes-Grajeda; Alberto Hidalgo-Bravo; Rafael Velázquez-Cruz
Frontiers in Endocrinology · 2026
* Correspondence: Alberto Hidalgo-Bravo, dr_genetica@yahoo.com; Rafael Velázquez-Cruz, rvelazquez@inmegen.gob.mx†Present address: Adriana Becerra-Cervera, Dirección General de Atención a la Salud (DGAS)-UNAM, Ciudad de México, Mexico
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:58:21.210438+00:00
DOI: 10.3389/fendo.2026.1824756 · PMC13485816